Press Center

MEDIA INQUIRIES:
We welcome members of the press to contact our Communications team at communication@pentafoundation.org or by phone +39 348 6151202 with any media-related inquires or interview requests.

30/06/2022 – Il vaccino Pfizer-BioNTech BNT162b2 (Comirnaty) offre una protezione moderata dalla variante Omicron nei bambini dai 5 agli 11 anni

Leggi il comunicato stampa

30/06/2022 – Study reveals moderate effectiveness of Pfizer Covid-19 vaccine against Omicron in children aged 5-11

Read the Press Release

26/04/2022 – GARDP study reveals that babies are increasingly dying of neonatal sepsis caused by drug-resistant bacterial infections

Read the Press Release

26/04/2022 – Uno studio di GARDP rivela che i neonati muoiono sempre più frequentemente per sepsi neonatale causata da infezioni batteriche resistenti ai farmaci

Leggi il comunicato stampa

24/01/2022 – European RBDCOV project to study HIPRA’s COVID-19 vaccine in children adolescents and immunocompromised patients

Read the Press Release

30/12/2021 – Easy to take medicine better at suppressing HIV in children

Read the Press Release

27/11/2021 – NeoVanc: New study finds no clear benefit from a shorter optimised vancomycin treatment in babies with Gram positive late onset sepsis

Read our Press Release

15/11/2021 – VERDI Project launches

Read our Press Release

02/07/2021 – New data on the duration of immune protection against SARS-CoV-2 in children

Read our Press Release

16/06/2021 – NeoIPC: una nuova collaborazione internazionale per migliorare le strategie di prevenzione e di controllo delle infezioni neonatali

Leggi il comunicato stampa

19/05/2021 – NeoIPC, a project seeking to reduce the transmission of resistant bacteria in neonatal intensive care units, has just launched

Read our Press Release

21/04/2021 – CORONA: COVID-19 and children: an Italian-led project supported by the UniCredit Foundation to study the impact of the coronavirus on children

Download

21/04/2021 – CORONA: bambini e COVID-19. Un progetto a guida italiana sostenuto da UniCredit Foundation per studiare l’impatto del coronavirus sui bambini

Leggi il comunicato stampa

03/02/2021 – New European-African collaboration to develop UNIVERSAL treatments for children living with HIV

Learn more

01/10/2020 – conect4children: First site open for patient recruitment in KD-CAAP Study

Learn more

25/07/2019 – Penta and CROMSOURCE Announce their Partnership to Improve Paediatric Drug Development

Download

01/04/2019 – University of Antwerp, bioMérieux, and Wellcome Trust to coordinate VALUE-Dx, a European Public-Private Partnership to fight antimicrobial resistance through diagnostics

Download

28/02/2019 – GARDP and Penta partner to accelerate the development of children’s antibiotics to tackle AMR

Download